000
| 01565nam 2200349zi 4500 |
---|
001 | 9.940682 |
---|
003 | CaOODSP |
---|
005 | 20240830154509 |
---|
006 | m o d f |
---|
007 | cr |n||||||||| |
---|
008 | 240717t20242024onc ob f00| 0 eng d |
---|
020 | |a9780660728230 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aH164-379/2024E-PDF |
---|
245 | 00|aGuidance document : |bswitching from prescription to non-prescription status. |
---|
264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2024. |
---|
264 | 4|c©2024 |
---|
300 | |a1 online resource (64 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Lignes directrices : changement de statut de vente de « sur ordonnance » à « sans ordonnance ». |
---|
500 | |a"Date adopted: 2014-05-07. Revised date: 2024-08-14. Effective date: 2024-10-13." |
---|
504 | |aIncludes bibliographical references. |
---|
650 | 0|aDrugs|xGovernment policy|zCanada. |
---|
650 | 0|aDrugs, Nonprescription|xGovernment policy|zCanada. |
---|
710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
---|
775 | 08|tLignes directrices : |w(CaOODSP)9.940683 |
---|
856 | 40|qPDF|s911 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H164-379-2024-eng.pdf |
---|
856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/switching-prescription-non-prescription-status.html |
---|